Intelligent Investor

Melodiol Global Health Limited (ASX: ME1) - Announcements

Current share price for ME1 : $0.002 0.001 (25%)

ASX company news and announcements for Melodiol Global Health Limited (ME1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Melodiol Global Health Limited (ME1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Melodiol Global Health Limited (ME1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Melodiol Global Health Limited (ME1)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$1 Proposed issue of securities - ME1 21 Feb 2024 11:19AM $0.014 $0.002 $0.002 fallen by 89.29%
$1 Proposed issue of securities - ME1 21 Feb 2024 11:19AM $0.014 $0.002 $0.002 fallen by 89.29%
$1 Proposed issue of securities - ME1 21 Feb 2024 11:19AM $0.014 $0.002 $0.002 fallen by 89.29%
$1 Capital Raising & Corporate Update 21 Feb 2024 11:19AM $0.014 $0.002 $0.002 fallen by 89.29%
$1 Trading Halt 19 Feb 2024 9:27AM $0.014 $0.002 $0.002 fallen by 89.29%
$1 Mernova Continues Strong Performance in Q1 FY24 12 Feb 2024 9:30AM $0.015 $0.002 $0.002 fallen by 90%
$1 HHI Revenue Update 7 Feb 2024 9:30AM $0.013 $0.002 $0.002 fallen by 88.46%
$1 Mernova Revenue Update 5 Feb 2024 9:15AM $0.016 $0.002 $0.002 fallen by 90.63%
$1 Appendix 2A x2 and Secondary Trading Notice 2 Feb 2024 4:43PM $0.016 $0.002 $0.002 fallen by 90.63%
$1 Completion of Share Consolidation 2 Feb 2024 12:59PM $0.016 $0.002 $0.002 fallen by 90.63%
$1 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2024 7:12PM $0.017 $0.002 $0.002 fallen by 91.18%
$1 Results of Meeting 23 Jan 2024 1:31PM $0.001 $0.002 $0.002 risen by 50%
$1 Change of Director's Interest Notice x 2 19 Jan 2024 5:12PM $0.001 $0.002 $0.002 risen by 50%
$1 Notification of cessation of securities - ME1 19 Jan 2024 5:09PM $0.001 $0.002 $0.002 risen by 50%
$1 Mernova Revenue Update and Placement 16 Jan 2024 1:27PM $0.002 $0.002 $0.002 fallen by 0%
$1 Application for quotation of securities - ME1 16 Jan 2024 1:12PM $0.002 $0.002 $0.002 fallen by 0%
$1 Proposed issue of securities - ME1 16 Jan 2024 1:10PM $0.002 $0.002 $0.002 fallen by 0%
$1 Notification of cessation of securities - ME1 27 Dec 2023 11:13AM $0.002 $0.002 $0.002 fallen by 0%
$1 Consolidation/Split - ME1 22 Dec 2023 9:43AM $0.002 $0.002 $0.002 fallen by 25%
$1 Notice of General Meeting/Proxy Form 22 Dec 2023 9:43AM $0.002 $0.002 $0.002 fallen by 25%
$1 Proposed issue of securities - ME1 22 Dec 2023 9:35AM $0.002 $0.002 $0.002 fallen by 25%
$1 Proposed issue of securities - ME1 22 Dec 2023 9:33AM $0.002 $0.002 $0.002 fallen by 25%
$1 Proposed issue of securities - ME1 22 Dec 2023 9:30AM $0.002 $0.002 $0.002 fallen by 25%
$1 Proposed issue of securities - ME1 22 Dec 2023 9:27AM $0.002 $0.002 $0.002 fallen by 25%
$1 Company Secretary Appointment/Resignation 22 Dec 2023 9:25AM $0.002 $0.002 $0.002 fallen by 25%

51 - 75 of 215 results

Page 3 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.